Novavax Inc. Stock Sheds 12.2%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Novavax Inc. plunged 12.2% to $8.76 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.4% to 25,366.09 and Dow Jones Industrial Average falling 0.4% to 52,297.09.

This was the stock's third consecutive day of losses.

Novavax Inc. closed 34.6% short of its 52-week high of $13.39, which the company achieved on October 5th.

The stock underperformed when compared to some of its peers, as Johnson & Johnson rose 1.1% to $283.52, Pfizer Inc. fell 2.1% to $28.83, and Merck & Co. Inc. fell 0.16% to $146.95.

Trading volume totaled 7.0 million, compared to the 50-day average of 7.1 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 12, 2026 16:33 ET (21:33 GMT)